[Coagulation and fibrinolysis system in bladder tumor. 2. Effect of fibrinolytic and anti-fibrinolytic agents on BBN-induced rat bladder tumor].
D000818:Animals; D002085:Butylhydroxybutylnitrosamine; D002295:Carcinoma, Transitional Cell / Q000139:chemically induced / Q000188:drug therapy*; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D008297:Male; D009602:Nitrosamines; D051381:Rats; D011919:Rats, Inbred Strains; D014148:Tranexamic Acid / Q000627:therapeutic use*; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced / Q000188:drug therapy*; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*
D003509:Cyclohexanecarboxylic Acids; D009602:Nitrosamines; D002085:Butylhydroxybutylnitrosamine; D014148:Tranexamic Acid; D014568:Urokinase-Type Plasminogen Activator